The Biologics Wound Care Products Market is Estimated to Surpass US$2.3 Billion with a CACR of 6.9% Over the Forecast Period by 2028 | Smith & Nephew Plc., Organogenesis, Inc.

Biologics for wound care are advanced bio-engineered products used for non-recoverable lower limit wounds. The demand for biologic wound care products is expected to completely increase as early diabetic ulcer intercession can prevent serious complexities such as illness, hospitalization and removal. The market for biologic wound care products is expected to gain a critical footing, as affordable skin substitutes have clinical evidence and testing for adequacy in wound repair.

Request a PDF brochure with the latest information here @ https://www.coherentmarketinsights.com/insight/request-pdf/1506

The global wound care biologics market was estimated at US$1.2 billion in 2016 and is expected to grow at a strong CAGR of 6.9% over the forecast period (2017-2025).

The high prevalence of diabetes is invoked to support the growth of the market

The market for wound care biologics is expected to gain a foothold, with an increase in the global prevalence of diabetes, as diabetic patients are prone to create diabetic ulcers. According to the Global Diabetes Community, 2017, 422 million adults are expected to be living with diabetes worldwide, and this figure is expected to rise to 642 million by 2040. Additionally, according to the Journal of Foot and Ankle Surgery, 2016, expansion 40+. The Advances in Wound Care Journal, 2015 also reported that 15% to 20% of the diabetic population is likely to promote chronic, non-repairing foot wounds. Therefore, biologic wound care products offer patients a financially savvy choice to monitor chronic wounds, thereby reducing the monetary burden of patients.

However, the high cost of skin charting and similar biologics is a significant impediment to market growth. For example, as reported in Advances in Skin Substitutes Journal, 2014, the cost for each 1% body surface area covered with Epicel is estimated to be over US$13,000. This thus incentivizes to broaden the reception of the optional and convenient wound care products, which are relied upon to negatively influence the growth of the market.

Asia-Pacific Market to Show Fastest Growth Over Forecast Period

Asia-Pacific is expected to show tremendous growth in the global wound care biologics market during the forecast period. This is inferred from the high frequency of diabetic patients in Asian countries. According to Diabetes Research Foundation of India, 2016, about 60% of the total population with diabetes lives in Asia, with about half in China and India. The Foundation further states that the Western Pacific has revealed more than 138.2 million people with diabetes, with the number expected to reach 201.8 million by 2035.

Get sample report with latest Covid19 analysis @ https://www.coherentmarketinsights.com/insight/request-sample/1506

Additionally, increasing clinical tourism in Asia-Pacific is a significant driver for market growth. The amount of unknown patients is increasing, inferred from reasonable treatment works with cadres in hospitals for wound care. As indicated by the Brink Global Risk Center overview, 2017, about 4 million clinical tourists traveled to India for medical care administrations, 3.5 million unknown patients went to Thailand and 900,000 patients to Singapore in 2016, with this number expected to increase by 10%-14% by 2020.

Increasing Frequency of Chronic Wounds and Ulcers to Accelerate Market Growth

Chronic wounds mainly affect the well-being and personal satisfaction of patients and their families, causing torment, passionate pressure, limitation of daily exercise, despondency, pain and nervousness, with prolonged stay in medical clinic and chronic sadness. As noted in the Advances in Wound Care Journal, 2015, chronic leg and foot ulcers normally last about a year, with recurrence affecting up to 65% of patients, leading to loss of ability and decreased satisfaction personal. This is also a key reason for the gloom. The increasing rate of horrific accidents, such as accidents and fires causing consumption, fundamental illnesses, anti-toxin safety, chronic illnesses, medical procedures and the versatility of the disabled, are the predominant factors leading to an increase the frequency of chronic wounds. The World Health Organization (WHO) also indicates that burns are the main source of gloom, including delayed hospitalization, distortion and disability-adjusted life year (DALY) lost in countries with low and medium salary. Accordingly, these factors are considered as the major consideration supporting the growth of Particleboard Market over the forecast period.

North America is considered to be a predominant region in the wound care biologics market, which is inferred from the increasing occurrence of non-recoverable chronic wounds that represent a financial burden for the healthcare setting. According to the American Diabetes Association, 2016, the normal expense for recovery from a solitary foot ulcer is US$8,000 and that for a major removal is $45,000. Additionally, venous leg ulcers are the most widely recognized wound type in the United States, affecting approximately 2 million people.

Major manufacturers working in the global wound care biologics market are Osiris Therapeutics, Inc., Amino Technology LLC, Solsys Medical LLC, Alphatec Holdings, Inc., Skye Biologics, Integra Lifesciences Holdings Corporation, Organogenesis, Inc., and Smith & Nephew Plc.

Buy this full business report with a flat rate discount of 2000 USD @ https://www.coherentmarketinsights.com/promo/buynow/1506

Reasons to buy this report

Current and future prospects of the Biologics Wound Care Products Market in both developed and emerging markets
• The segment that is expected to dominate the market as well as the segment that holds the highest CAGR during the forecast period.
• Regions/countries expected to experience the fastest growth rates during the forecast period
• The latest developments, market shares and strategies employed by major market players

Contents

  1. Research objective and hypothesis
    • Research objectives
    • Hypotheses
    • Abbreviations
  2. Market scope
    • Description of the report
      • Market definition and scope
    • Summary
      • Market extract, by product type
      • Market Extract, By Application
      • Market Extract, by End User
      • Market extract, by region
    • Consistent Opportunity Map (COM)
  3. Market dynamics, regulation and trend analysis
    • Market dynamics
      • Drivers
      • Constraints
      • Market opportunities
      • Industry trends
    • Technological advances
    • Regulatory scenario
    • Refund scenario
    • Highlights
    • PEST analysis
    • Epidemiology
    • Impact analysis
  4. Global Wound Care Biologics Market, by Product Type, 2015-2025, (USD Million)
    • introduction
      • Market share analysis, 2015 and 2025 (%)
      • Annual Growth Analysis, 2016-2025
      • Industry trends
    • Biological Substitutes of the Skin
      • introduction
      • Market size & forecast and annual growth, 2015-2025, (USD Million)
    • Enzyme-based formulations
      • introduction
      • Market size & forecast and annual growth, 2015-2025, (USD Million)
    • Growth factors
      • introduction
      • Market size & forecast and annual growth, 2015-2025, (USD Million)
  5. Global Wound Care Biologics Market, by Application, 2015-2025, (USD Million)
    • introduction
      • Market share analysis, 2015 and 2025 (%)
      • Annual Growth Analysis, 2016-2025
      • Industry trends
    • Chronic wounds
      • introduction
      • Market size & forecast and annual growth, 2015-2025, (USD Million)
      • Industry trends
        • Diabetic Foot Ulcers
        • Venous leg ulcers
        • Bedsores
    • Acute wounds
      • introduction
      • Market size & forecast and annual growth, 2015-2025, (USD Million)
      • Industry trends
  6. Global Wound Care Biologics Market, by End User, 2015-2025, (USD Million)
    • introduction
      • Market share analysis, 2015 and 2025 (%)
      • Annual Growth Analysis, 2016-2025
      • Industry trends
    • Hospitals
      • introduction
      • Market size & forecast and annual growth, 2015-2025, (USD Million)
      • Industry trends
        • Hospitalization Parameters
        • Ambulatory parameters
    • Clinics
      • introduction
      • Market size & forecast and annual growth, 2015-2025, (USD Million)
    • Ambulatory surgery centers
      • introduction
      • Market size & forecast and annual growth, 2015-2025, (USD Million)
    • Home care settings
      • introduction
      • Market size & forecast and annual growth, 2015-2025, (USD Million)
  7. Global Wound Care Biologics Market, by Region, 2015-2025, (USD Million)
    • introduction
      • Market share analysis, by region, 2015 and 2025 (%)
      • Analysis of annual growth, for regions, 2016-2025
    • North America
      • Market size and forecast, by product type, 2015-2025, (USD Million)
      • Market size and forecast, by application, 2015-2025, (USD Million)
      • Market size and forecast, by end-user, 2015-2025, (USD Million)
      • Market size and forecast, by country, 2015-2025, (USD Million)
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • Russia
      • The rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of APAC
    • Middle East
      • GCC
      • Israel
      • Rest of the Middle East
    • Africa
      • South Africa
      • central Africa
      • North Africa

See the press release: https://www.coherentmarketinsights.com/press-release/wound-care-biologics-market-to-surpass-us-23-billion-by-2025-834

About Us:

Coherent Market Insights is a global market intelligence and advisory organization that provides syndicated research reports, custom research reports and advisory services. We’re known for our actionable insights and genuine reports in a variety of fields, including aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and virtually any field and an exhaustive list of subdomains under the sun. We create value for our clients through our highly reliable and accurate reports. We are also committed to playing a leadership role in providing insights in various post-COVID-19 sectors and to continuing to deliver measurable and sustainable results to our clients.

Contact:

Consistent market information
1001 4th Ave, #3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Antoine L. Cassell

Check Also

Sue Ryder: How volunteering at Preston’s state-of-the-art neuro-care center helps more than residents

Caroline volunteers at Sue Ryder’s Lancashire Neurological Care Center in Fulwood two days a week …

Leave a Reply

Your email address will not be published.